Drug Trial Radar · NCT02877927
Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI
Last checked: Nov 20, 2026Latest source record: Nov 30, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
735
Actual
Start
Aug 2016
Primary completion
May 26, 2017
Study completion Jun 6, 2017
Sponsor
- Lead sponsor
- Paratek Pharmaceuticals IncIndustry
- Sponsor type
- Industry
- First posted
- Aug 24, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and efficacy of omadacycline as compared to linezolid in the treatment of adults with acute bacterial skin and skin structure infections.
Conditions
- Bacterial Infections
- Skin Structures and Soft Tissue Infections
Interventions
OmadacyclineDrug
po tablets
LinezolidDrug
po tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Early Clinical ResponseTime frame: Screening; 48 to 72 hours after the first dose of test article
Locations
50 sites in 1 country. Site status is shown where the registry gives one.
Site 620
Birmingham, Alabama
Site 642
Mobile, Alabama
Site 616
Anaheim, California
Site 601
Anaheim, California
Site 636
Bakersfield, California
Site 606
Buena Park, California
Site 604
Chula Vista, California
Site 659
Huntington Beach, California
Site 608
La Mesa, California
Site 618
Laguna Hills, California
Site 612
Long Beach, California
Site 648
Modesto, California
Site 610
Oceanside, California
Site 615
San Diego, California
Site 621
San Diego, California
Site 613
San Francisco, California
Site 603
Stockton, California
Site 650
Torrance, California
Site 646
Ventura, California
Site 614
DeLand, Florida
Site 655
Fort Myers, Florida
Site 656
Homestead, Florida
Site 631
Miami, Florida
Site 658
Miami, Florida
Site 654
Miami, Florida
Site 626
Miami, Florida
Site 637
Miami, Florida
Site 653
Miami, Florida
Site 641
Miami, Florida
Site 645
Miami, Florida
Site 640
Miami Lakes, Florida
Site 662
Miami Lakes, Florida
Site 609
Saint Cloud, Florida
Site 644
Council Bluffs, Iowa
Site 657
Boston, Massachusetts
Site 617
St Louis, Missouri
Site 602
Butte, Montana
Site 623
Las Vegas, Nevada
Site 630
Somers Point, New Jersey
Site 647
Jackson Heights, New York
Showing 40 of 50 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.